tiprankstipranks
Hypera SA (HYPMY)
OTHER OTC:HYPMY

Hypera SA (HYPMY) Stock Price & Analysis

5 Followers

HYPMY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.84 - $9.49
Previous Close$6.19
Volume5.48K
Average Volume (3M)11.34K
Market Cap
$3.90B
Enterprise Value$5.25B
Total Cash (Recent Filing)R$2.86B
Total Debt (Recent Filing)R$9.68B
Price to Earnings (P/E)11.9
Beta0.40
May 09, 2024
EPS EstimateN/A
Dividend Yield2.7%
Share Statistics
EPS (TTM)0.52
Shares Outstanding632,766,400
10 Day Avg. Volume9,488
30 Day Avg. Volume11,344
Standard Deviation0.11
R-Squared0.21
Alpha-0.00293
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%0.02%99.97%
0.00%
Insiders
0.02% Other Institutional Investors
99.97% Public Companies and
Individual Investors

HYPMY FAQ

What was Hypera SA’s price range in the past 12 months?
Hypera SA lowest stock price was $5.84 and its highest was $9.49 in the past 12 months.
    What is Hypera SA’s market cap?
    Currently, no data Available
    When is Hypera SA’s upcoming earnings report date?
    Hypera SA’s upcoming earnings report date is May 09, 2024 which is in 20 days.
      How were Hypera SA’s earnings last quarter?
      Hypera SA released its earnings results on Mar 13, 2024. The company reported $0.098 earnings per share for the quarter, beating the consensus estimate of N/A by $0.098.
        Is Hypera SA overvalued?
        According to Wall Street analysts Hypera SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hypera SA pay dividends?
          Hypera SA pays a Quarterly dividend of $0.01 which represents an annual dividend yield of 2.7%. See more information on Hypera SA dividends here
            What is Hypera SA’s EPS estimate?
            Hypera SA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Hypera SA have?
            Hypera SA has 633,420,840 shares outstanding.
              What happened to Hypera SA’s price movement after its last earnings report?
              Hypera SA reported an EPS of $0.098 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.215%.
                Which hedge fund is a major shareholder of Hypera SA?
                Among the largest hedge funds holding Hypera SA’s share is Fisher Asset Management LLC. It holds Hypera SA’s shares valued at 1M.
                  ---

                  Hypera SA Stock Smart Score

                  2
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -15.77%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  15.11%
                  Trailing 12-Months
                  Asset Growth
                  14.20%
                  Trailing 12-Months

                  Company Description

                  Hypera SA

                  Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the major pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure.
                  ---

                  HYPMY Earnings Call

                  Q4 2024
                  0:00 / 0:00
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AbbVie
                  GlaxoSmithKline
                  Sanofi
                  Pfizer
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis